ALK tracks worst day in a year on 2028 margin target miss

Alk-Abello A/S

04/06/2024 09:01

** ALK-Abello  ALKb.CO  shares are down nearly 7% after the
Danish pharmaceutical company launched new growth strategy and
financial ambitions for 2028 
    ** The company aims at minimum +10% compound annual growth
rate and EBIT margin of 25% until 2028
    ** Jefferies says that while revenue ambition is as
expected, the flat EBIT margin target "likely disappoints,"
missing consensus estimate of about 27.5%
    ** ALK confirmed its 2025 earnings margin ambition of about
25% 
    ** If losses hold, the stock will see its worst day since
June 2023
    

 (Reporting by Anna Chaberska)
 ((Anna.chaberska@thomsonreuters.com))